Clinical Trials Logo

Filter by:
NCT ID: NCT05162222 Completed - Clinical trials for Healthy Participants

A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicamtiv in Healthy Participants

Start date: December 15, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effects of co-administration of itraconazole or diltiazem on the single-dose pharmacokinetics of danicamtiv in healthy participants.

NCT ID: NCT05162183 Completed - Diabetes Clinical Trials

Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data

Start date: September 1, 2019
Phase:
Study type: Observational

Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.

NCT ID: NCT05162053 Completed - Clinical trials for Acute Coronary Syndrome

PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers

Start date: December 9, 2021
Phase: Phase 1
Study type: Interventional

This clinical study will adopt an open-label, randomized, multiple-dose, two-crossover design to explore the pharmacokinetic and pharmacodynamic profiles of Vicagrel Capsules and Clopidogrel Tablets in Healthy Subjects with Different CYP2C19 Metabolizers

NCT ID: NCT05161897 Completed - Clinical trials for Cardiovascular Diseases

Individualized Nutrition Therapy for Preventing or Delaying Onset of Type-2 Diabetes

Start date: August 25, 2022
Phase: N/A
Study type: Interventional

The overall aim of this feasibility study is to conduct a randomized, controlled intervention providing adults with prediabetes either an individualized nutrition therapy (INT) intervention that contains individualized dietary goal-setting components, the goal being to improve blood glucose, reduce CVD risk factors, and therefore postpone the onset of diabetes and related cardiovascular disease, or standard-of-care generalized dietary recommendation (SOC). The hypothesis is that the INT arm will experience greater benefits in some or all of the following primary outcome variables: improvement in postprandial blood glucose, oral glucose tolerance test, fasting insulin, and calculated insulin sensitivity (HOMA) in individuals with prediabetes. Secondary outcome variables are improved markers of inflammation, antioxidant status, blood lipids, blood pressure, and endothelial function.

NCT ID: NCT05161806 Completed - Clinical trials for Neovascular Age-related Macular Degeneration (nAMD)

Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe

Start date: March 11, 2022
Phase: Phase 3
Study type: Interventional

This was an open-label, single arm, multicenter, Phase IIIb study in subjects with (wet) nAMD, eligible for IVT aflibercept treatment.

NCT ID: NCT05161260 Completed - Breast Cancer Clinical Trials

Breathwork App for Cancer Survivors

Start date: November 17, 2021
Phase: N/A
Study type: Interventional

Cancer survivorship is associated with many long-term chronic health issues that arise as a result of cancer treatment protocols. Non-pharmacological lifestyle and mind-body interventions have been shown to be effective and critical components of a total-health strategy for cancer survivors. PranaScience Institute seeks to develop and test a novel group video app for home-based delivery of a Yogic Breathing intervention that reduces symptoms of cancer treatment survival and supports total-health.

NCT ID: NCT05161234 Completed - Clinical trials for Rheumatoid Arthritis

A Clinical Utility Study of PrismRA for Rheumatoid Arthritis

DRIVE
Start date: March 3, 2022
Phase:
Study type: Observational

A clinical utility study for PrismRA testing therapeutic response in patients with rheumatoid arthritis.

NCT ID: NCT05161208 Completed - Dry Eye Clinical Trials

OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers

Start date: December 3, 2021
Phase: Phase 4
Study type: Interventional

This study is a single center, prospective, randomized, controlled, double-masked, two-arm investigator-initiated study to investigate the efficacy of OC-01 (varenicline) nasal spray on the signs and symptoms of dry eye disease in daily soft contact lens wearers.

NCT ID: NCT05161156 Completed - COPD Clinical Trials

Bioequivalence Study of Tiotropium Bromide Inhalation Powder

Start date: March 24, 2022
Phase: Phase 3
Study type: Interventional

This study is to characterize the pharmacodynamic characteristics and to assess the therapeutic bioequivalence after single dose of Tiotropium Bromide Inhalation Powder-test relative to Tiotropium Bromide Inhalation Powder-reference in Adult Patients with Chronic Obstructive Pulmonary Disease (COPD) as primary objective

NCT ID: NCT05161065 Completed - Atrial Fibrillation Clinical Trials

Comparison of QT Interval Readings Between Smartwatch Combined With Cardiologs Artificial Intelligence and 12-lead ECG

Start date: February 12, 2022
Phase:
Study type: Observational

The WatchQT study will compare the performance of a smartwatch combined with Cardiologs ECG AI Analysis system in monitoring corrected QT (QTc) intervals with that measured on a manually read 12-lead ECG in subjects with Normal Sinus Rhythm (NSR) during antiarrhythmic drug (AAD) initiation and follow-up at the hospital.